 toxic abil prolifer activ numer type immunocompet cell surviv lymphocyt consider interest use immunotherapi malign studi date activ malign consider toxic care prescreen select patient appropri manag toxic advers outcom studi effect intrigu evid interact immune/cytokin system neuroendocrin cardiovascular system studi anim model central role intact immun system mani toxic sever advers effect appear cytokin product pathogenesi manifest toxic hope toxic approach therapi sever lesson experi like applic clinic develop cytokin